ReviewExperimental and therapeutic medicine2026
NLRC3 in septic immunosuppression: Variation in expression and mechanisms of mediating immune cell dysfunction (Review).
Review in Experimental and therapeutic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sepsis is a life-threatening disease caused by a dysregulated host immune response to infection. In the acute phase of sepsis, patients tend to experience a hyperinflammatory state; however, in addition to facilitating the elimination of invading pathogens, this severe hyperinflammatory response can also lead to damage to the host. Thus, to maintain immune system homeostasis, counterregulatory immune responses, referred to as compensatory anti-inflammatory responses (CARs), are initiated. However, in the context of sepsis, the stabilization of the immune system cannot be sustained and protracted CARs can lead to an immunosuppressive state, which makes septic patients highly susceptible to secondary infection and high mortality. Various studies have indicated that the expression of NOD-like receptor (NLR) with a caspase activation and recruitment domain 3 (NLRC3), a member of the NLR family, tends to decrease several hours to days after the onset of infection but afterward increases over time and can mediate the dysfunction of immune effector cells in numerous ways, playing a crucial role in the development of septic immunosuppression. Therefore, this review summarized the expression variation of NLRC3 and the mechanisms through which it mediates immune cell dysfunction in different phases of sepsis, seeking to inspire future immune therapy for modulating septic host immune balance and reversing the immunosuppressive state, with a focus on NLRC3 as a target.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.